Google Inc (GOOGL) To Turn Another Crazy Idea Into Reality

Google Inc (NASDAQ:GOOGL) is known for turning seemingly crazy ideas into reality. It even has a dedicated ‘semi-secret’ project facility called Google X for research purposes. Most notable among Google X projects are the Google Glass and the Google’s driverless car. Techie hotshots and former Google employees, Bret Taylor, Carl Sjogreen and Ben Legg discussed with Cory Johnson about such ‘out of the world’ projects on Bloomberg West.

Google GOOG

Google Inc (NASDAQ:GOOGL) Maps co-creator and former Facebook Inc (NASDAQ:FB) Chief Technology Officer Bret Taylor mentioned his thoughts on what it is that made people think about venturing far beyond the accepted boundary and work on such incredible projects. “When I got to Google, I remember the most distinctive feeling I had, was how ambitious and academic it felt,” he said. He was certain that though such projects are ridiculed at the beginning, it does not deter the enthusiasm and effort that Google puts into developing them right from conception to market availability.

Google Inc (NASDAQ:GOOGL)’s approach to research and development is radically different from other companies. They want to create products that are not 10%, but ten times better than their competitors. It is this 10x mentality that has helped Google actualize even the most ambitious projects such as Google Street View said Shadow Puppet CEO and former Google Group Product Manager, Carl Sjogreen.

Self-driving cars aside, where Google Inc (NASDAQ:GOOGL) really rocks is its advertising technology. It is a pioneer in this field and it is where Google makes it major money. This can be considered to be a fine example of how Google has been able to convert some really cool innovations into products that actually earn revenue. Ben Legg, Ad-knowledge CEO, and former Google Europe COO, tells that to make any significant difference to its current standing, Google has to innovate in the 10 billion brackets.

“To really make a difference to Google’s financial results, they need to add a $10 billion business to what they are doing now, because even a billion dollar business would not make any difference,” he said.

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!